MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202527027821 A) filed by E-Nitiate Biopharmaceuticals (HANGZHOU) Co. Ltd., Zhejiang, China, on March 25, for 'prodrug of jak kinase inhibitor.'
Inventor(s) include Liu, Pengfei; Shen, Wang; Bai, Rujun; Ding, Yue; and Ding, Shizhe.
The application for the patent was published on April 25, under issue no. 17/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a prodrug containing a JAK inhibitor, a composition, and use thereof . In particular, the present invention relates to a compound represented by formula (II), a pharmaceutical composition containing the compound of the present invention,...